Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (24)
  • 2024 (29)
  • 2023 (54)
  • 2022 (90)
  • 2021 (71)
  • 2020 (10)
  • 2019 (6)
  • 2018 (2)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Press Conferences (68)

Drug Name

  • Fentanyl (64)
  • Opioids (51)
  • Oxycodone (49)
  • Cocaine (23)
  • Methamphetamine (19)
  • Synthetic Opioids (17)
  • Heroin (13)
  • Hydromorphone (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • Marijuana (Cannabis) (2)
  • Ecstasy/MDMA (1)
  • GHB (1)

Field Division

  • Washington, DC (55)
  • St. Louis (33)
  • New York (23)
  • Chicago (20)
  • Headquarters (18)
  • New Jersey (17)
  • Miami (16)
  • El Paso (13)
  • Atlanta (12)
  • Seattle (12)
  • Dallas (11)
  • Houston (9)
  • Rocky Mountain (7)
  • San Francisco (7)
  • New England (6)
  • New Orleans (6)
  • Los Angeles (5)
  • Louisville (5)
  • Omaha (5)
  • San Diego (5)
  • Phoenix (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Sweeping DEA Operation Targets Pharmacy Burglaries and the Illegal Sale of Addictive Prescription Medications

August 29, 2024
WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...
August 29, 2024
PRESS RELEASE

Ohio Men Sentenced for Burglarizing Illinois and Missouri Pharmacies of Controlled Substances

August 29, 2024
EAST ST. LOUIS, Ill. – A district court judge sentenced two Columbus, Ohio, men to federal prison for burglarizing several pharmacies of oxycodone, hydrocodone and morphine pills with intent to illegally distribute the controlled substances. George H. Cunningham, 42, was sentenced to 100 months in prison and Tarvin M. Hamler...
August 29, 2024
PRESS RELEASE

DEA Breaks Ground on New Laboratory in New Hampshire

August 28, 2024
LONDONDERRY, NH –The U.S. Drug Enforcement Administration was joined today by U.S. Attorney for the District of New Hampshire, Jane Young, representatives from the U.S. General Services Administration (GSA), New England HIDTA, the New Hampshire Department of Safety, the Town of Londonderry, and members of the New Hampshire federal congressional...
August 28, 2024
PRESS RELEASE

Five Defendants, Including Two Doctors, Charged in Connection with Actor Matthew Perry's Fatal Overdose Death Last Year

August 19, 2024
LOS ANGELES – A licensed physician and an alleged San Fernando Valley drug dealer were arrested today in connection with the death of actor Matthew Perry, who suffered a fatal ketamine overdose in October 2023. In total, five defendants, including two doctors, have been charged in this matter, according to...
August 19, 2024
PRESS RELEASE

Cartel-Linked Minnesotan Indicted for Operating a Mexico-Based Drug Trafficking Operation

August 06, 2024
MINNEAPOLIS – The Drug Enforcement Administration (DEA) Omaha Division led an investigation in partnership with state, local and federal law enforcement agencies in which 15 individuals were charged in a Mexico-based drug trafficking conspiracy that distributed methamphetamine, cocaine and fentanyl sourced by the Sinaloa and CJNG Cartels throughout the Twin...
August 06, 2024
PRESS RELEASE

Utah Sets Record For Fentanyl Pill Seizures

July 25, 2024
SALT LAKE CITY - With less than six months remaining in 2024, the Drug Enforcement Administration's Rocky Mountain Field Division (RMFD) has already seized nearly 800,000 fentanyl pills in Utah - a new record. In operations between January 1 and June 30, 2024, more than 774,000 fentanyl pills were seized...
July 25, 2024
PRESS RELEASE

Jefferson County Doctor, Staffers Accused of Conspiracy, Health Care Fraud

July 08, 2024
ST. LOUIS – A doctor with an office in St. Louis and two employees have been indicted in U.S. District Court and accused of illegally prescribing controlled substances and health care fraud. Dr. David A. Parks, 66, James M. Bilderback, 58, both of Jefferson County, Missouri, and Michelle J. Scheer...
July 08, 2024
PRESS RELEASE

OptumRx Agrees to Pay $20M to Resolve Allegations that It Filled Opioid Prescriptions in Violation of the Controlled Substances Act

June 27, 2024
SAN DIEGO – OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act. The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013...
June 27, 2024
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

June 03, 2024
SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
June 03, 2024
PRESS RELEASE

Doctor Sentenced to 10 Years in Prison for Selling Opioid Prescriptions

May 24, 2024
WICHITA, Kan. – A former Kansas physician was sentenced to 10 years in prison following a jury trial conviction and a plea agreement based on charges for selling opioid prescriptions to customers without legitimate medical need for powerful pain medications. According to court documents, Steven R. Henson, 63, of Wichita...
May 24, 2024
Showing 31 - 40 of 289 results

Pagination

  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster